Monday, November 17, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Aware Inc Reports Q4 2023 Earnings Decrease in EPS but Increase in Total Revenue

Elaine Mendonca by Elaine Mendonca
March 13, 2024
in Breaking News
0
Technology Blockchain Markets and money
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Aware Inc.’s stock is taking a hit following the release of their Q4 earnings report for 2023. The company experienced a significant decline in earnings per share compared to the same period last year. In Q4 of 2023, Aware Inc. reported a net loss of $4.2 million, or $(0.20) per diluted share, a stark contrast to the $1.1 million net income they saw in the previous year.

Despite the decrease in EPS, the company did see a positive uptick in total revenue, which increased by 8% year-over-year to $4.4 million. However, operating expenses also rose substantially, reaching $8.9 million compared to $6.1 million in the previous year’s Q4. This led to an operating loss of $4.4 million, a significant increase from the $2 million loss in the same period last year.

On a more positive note, Aware Inc.’s adjusted EBITDA loss for the quarter showed some improvement from the previous year, coming in at $1.3 million.

AWRE Stock Performance Analysis: March 13, 2024 – Potential for Recovery After After-Hours Uptick

On March 13, 2024, the stock performance of AWRE was closely monitored by investors and analysts. According to data from CNN Money, AWRE was trading in the middle of its 52-week range and above its 200-day simple moving average. This indicates that the stock has been relatively stable in the long term.

However, on that particular day, AWRE experienced a significant drop in its share price. The stock closed at $1.62, which was a decrease of $0.19 or a 10.50% drop since the market last closed. This sudden drop may have been concerning for investors who were closely following the stock.

Despite the drop in the regular trading session, AWRE saw a slight uptick in after-hours trading. The stock rose by $0.04 after the market closed, which may have provided some relief to investors who were worried about the earlier decline.

Overall, the performance of AWRE on March 13, 2024, was a mix of both negative and positive movements. While the drop in the share price during the regular trading session was concerning, the slight increase in after-hours trading may indicate some potential for recovery in the future. Investors will continue to monitor the stock closely to see how it performs in the coming days and weeks.

AWRE Stock Analysis: Fluctuations in Financial Performance on March 13, 2024

On March 13, 2024, AWRE stock experienced some fluctuations in its financial performance based on the data provided by CNN Money. The company’s total revenue for the past year was reported at $18.24 million, showing a 13.97% increase compared to the previous year. However, the total revenue for the fourth quarter was $4.37 million, remaining flat compared to the previous quarter.

In terms of net income, AWRE reported a net loss of $7.31 million for the past year, which represents a significant decrease of 323.75% compared to the previous year. On the other hand, the net loss for the fourth quarter was $4.24 million, showing no change compared to the previous quarter.

Earnings per share (EPS) also saw a decline in performance for AWRE stock. The EPS for the past year was reported at -$0.35, reflecting a decrease of 335.67% compared to the previous year. Similarly, the EPS for the fourth quarter was -$0.20, showing a decrease of 473.01% compared to the previous quarter.

Overall, AWRE stock’s financial performance on March 13, 2024, indicates mixed results. Investors and analysts may need to closely monitor the company’s financial health and performance to assess its future prospects and potential for growth.

Tags: AWRE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Commercial (2)

Title Warren Wang Appointed CEO and Chairman of Hudson Acquisition I

Finance_ Chart up

Analysis of Nucor Options Trading Bearish Sentiment and Price Targets

IT-Healthcare

The Lucrative Growth of Investing in Intuitive Surgical

Recommended

Technology Blockchain Trading online

Calculating Shares Needed for Monthly Income from Cisco Systems Dividends

2 years ago
Abercrombie & Fitch Stock

Abercrombie & Fitch Shares Approach Critical Juncture

6 days ago

ESAB Corporation Analysts Bullish on Stock Growth

2 years ago
Navitas Semiconductor Corporation Stock

Navitas Semiconductor: A Battle Between Short-Term Pressures and Long-Term Strategy

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Bruker Shares: Navigating the Crossroads After a Sharp Downturn

Meta’s AI Ambitions Fuel Investor Divide

Hannover Re Shares Surge on Upbeat Financial Outlook

Synopsys Faces Securities Lawsuit Amid Major Corporate Overhaul

Sunnova Energy’s Final Chapter: Liquidation Complete as Solar Pioneer Ceases Operations

Disney’s Strategic Pivot: Navigating Challenges with Renewed Focus

Trending

Axsome Stock
Earnings

Axsome Therapeutics: Neuroscience Innovator Gains Momentum

by Andreas Sommer
November 17, 2025
0

The biotechnology sector has identified its latest standout performer: Axsome Therapeutics. This pharmaceutical firm is rapidly establishing...

BAE Systems Stock

BAE Systems Shares Surge on Strong Defense Orders

November 17, 2025
Zoetis Stock

Zoetis Shares: Is the Downturn Bottoming Out?

November 17, 2025
Bruker Stock

Bruker Shares: Navigating the Crossroads After a Sharp Downturn

November 17, 2025
Meta Stock

Meta’s AI Ambitions Fuel Investor Divide

November 17, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Axsome Therapeutics: Neuroscience Innovator Gains Momentum
  • BAE Systems Shares Surge on Strong Defense Orders
  • Zoetis Shares: Is the Downturn Bottoming Out?

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com